Item request has been placed!
×
Item request cannot be made.
×
Processing Request
1620P A phase II study of perioperative nalirifox in patients with resectable pancreatic ductal adenocarcinoma (rPDAC): Survival update and biomarkers analysis of the NITRO trial.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Melisi, D.1 (AUTHOR); Merz, V.2 (AUTHOR); Fazzini, F.1 (AUTHOR); Pietrobono, S.2 (AUTHOR); Zecchetto, C.3 (AUTHOR); Malleo, G.4 (AUTHOR); Landoni, L.4 (AUTHOR); Quinzii, A.1 (AUTHOR); Casalino, S.1 (AUTHOR); C. pesoni3 (AUTHOR); Gaule, M.3 (AUTHOR); Casetti, L.4 (AUTHOR); D'Onofrio, M.5 (AUTHOR); Gabbrielli, A.6 (AUTHOR); Bernardoni, L.6 (AUTHOR); Milleri, S.7 (AUTHOR); Butturini, G.8 (AUTHOR); Scarpa, A.9 (AUTHOR); Salvia, R.4 (AUTHOR); Bassi, C.4 (AUTHOR)
- Source:
Annals of Oncology. 2023 Supplement 2, Vol. 34, pS897-S897. 1p.
- Subject Terms:
No Comments.